Faecal calprotectin (FC) is now part of the new official European Crohn’s and Colitis Organisation (ECCO) and the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) guidelines.
Click here to read the ECCO IBD monitoring guidelinesFaecal calprotectin (FC) is now part of the new official European Crohn’s and Colitis Organisation (ECCO) and the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) guidelines.
Click here to read the ECCO IBD monitoring guidelinesFaecal Calprotectin is a new biomarker which is helping to save money for the NHS by preventing unnecessary procedures on patients by screening out patients with IBS who do not require endoscopies.
The symptoms of functional disorders such as Irritable Bowel Syndrome (IBS) and organic inflammatory intestinal disease (IBD) can be very similar in presentation but are two very different medical conditions.
The Workflow Revolution Continues for Serum Calprotectin June 29, 2023
New Presentation Format for UK NEQAS April 8, 2022
Point-of-Care Calprotectin Testing Just Got Easier with New and Improved Quantum Blue® III March 17, 2021
New App Helps Bowel Disease Patients Monitor Their Own Treatment February 24, 2021
Enjoy Effortless Pipetting with Tacta® Manual #Pipettes
Designed for your safety, while producing accurate and reliable results time after time.
Take advantage of a fantastic 45% discount on the Tacta Pipettes. Order online or quote offer code LV2402: https://files.alphalabs.co.uk/e-mags/LabVantage-2024-1/6/